Biogeneration Ventures raises $119M for new fund, adding a personal record to series of VC raises
The last few months, for all its economic upheaval, have been kind to biomedical venture firms.
ARCH raised a billion and a half, Flagship another billion, and a smattering of other funds from venBio to Atlas added a few hundred million each to new funds. In comparison to those American-based heavyweights, Netherlands-based Biogeneration Ventures (BGV) has been a considerably smaller player.
Yet they, too, just raised their largest fund yet: €105 million, or $118 million. The total nearly doubles what the firm had raised in 3 previous rounds.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.